Amylyx Pharmaceuticals, Inc. (AMLX)
27.79
-2.50
(-8.25%)
USD |
NASDAQ |
Nov 16, 16:00
27.79
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Shareholders Equity (Quarterly) : 753.74M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 753.74M |
| June 30, 2026 | 239.17M |
| March 31, 2026 | 273.16M |
| December 31, 2025 | 305.26M |
| September 30, 2025 | 332.00M |
| June 30, 2025 | 167.88M |
| March 31, 2025 | 201.42M |
| December 31, 2024 | 164.76M |
| September 30, 2024 | 196.20M |
| June 30, 2024 | 261.31M |
| March 31, 2024 | 324.44M |
| December 31, 2023 | 433.43M |
| September 30, 2023 | 418.40M |
| Date | Value |
|---|---|
| June 30, 2023 | 386.36M |
| March 31, 2023 | 352.65M |
| December 31, 2022 | 340.61M |
| September 30, 2022 | 144.03M |
| June 30, 2022 | 192.79M |
| March 31, 2022 | 240.95M |
| December 31, 2021 | 88.18M |
| September 30, 2021 | 115.28M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 5.337M |
| September 30, 2020 | 0.00 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 89.00B |
| ANI Pharmaceuticals, Inc. | 637.11M |
| Corcept Therapeutics, Inc. | 833.74M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 81.53B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 786.80M |
| Total Liabilities (Quarterly) | 33.06M |
| Debt to Equity Ratio | 0.0066 |
| Current Ratio | 26.81 |
| Net Debt Paydown Yield | 0.01% |